Britain’s Ashwagandha Safety Review Is Still Not Closed

The UK Committee on Toxicity discussed a third draft statement on ashwagandha on 8 September 2026, so the formal risk assessment remains open and no UK or EU conclusion has been published. A separate 90-day study of one branded extract in 62 adults reported no adverse signals, but it was supplier-funded.